pharma-company /Medicinal products /Active ingredients

Rx · PZN 17865106, 16352675, 20120002, 20701360

INBRIJA 33 mg hard capsules with powder for inhalation

German trade nameINBRIJA 33 mg Hartkapseln mit Pulver zur Inhalation

Active ingredientLevodopa

Consistently available

9.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Ambient max. 25 °C

Average purchase price (B2B)

~ €499

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

INBRIJA 33 mg hard capsules with powder for inhalation is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

INBRIJA 33 mg hard capsules with powder for inhalation contains the active ingredient Levodopa. 4 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 9.6 out of 10. The best-available pack was consistently available.


Pack sizes · 4 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
163526759.49.6~ €424
201200025.15.5~ €649
178651060.00.0N/A
207013600.00.0~ €424

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across 3 of 4 PZNs.